Adult surgery, 20% of the MCQ exam

Urology

Renal colic, urinary retention, haematuria, testicular emergencies, UTI and prostate disease. Prostate cancer testing is a shared-decision topic in Australia.

High-yield points

  • Testicular torsion: sudden severe pain, high-riding testis, absent cremasteric reflex; surgical exploration within 6 hours, do not delay for ultrasound.

  • Renal colic: non-contrast CT KUB; NSAIDs for pain; stones under 5 mm usually pass.

  • Obstructed infected kidney (stone with fever) is an emergency needing drainage (stent or nephrostomy) plus antibiotics.

  • Painless visible haematuria in an adult: suspect urothelial cancer; CT urogram and cystoscopy.

  • Uncomplicated cystitis in women (eTG): trimethoprim for 3 days, or nitrofurantoin, or cefalexin; cefalexin in pregnancy.

  • Acute urinary retention: catheterise, review drugs (anticholinergics, opioids), look for constipation; BPH is common.

  • PSA testing: requires informed shared decision-making; men who choose it are offered testing every 2 years from 50 to 69.

  • Asymptomatic bacteriuria is not treated except in pregnancy and before urological procedures.

India vs Australia

Where the answer the AMC marks correct differs from what’s usually taught in Indian MBBS.

  • PSA testing

    India (MBBS)

    Often ordered routinely in older men.

    Australia (AMC): what the exam expects

    No screening program. Discuss benefits and harms (overdiagnosis, biopsy risks) before testing, and document the patient's decision.

  • Uncomplicated cystitis in women

    India (MBBS)

    Fluoroquinolones or nitrofurantoin; high ESBL rates.

    Australia (AMC): what the exam expects

    eTG: trimethoprim 3 days, nitrofurantoin 5 days or cefalexin 5 days. Fluoroquinolones not first line.

  • Renal colic

    India (MBBS)

    Ultrasound and X-ray KUB.

    Australia (AMC): what the exam expects

    Largely the same management; non-contrast CT KUB is standard, with medical expulsive therapy for small distal stones.

The Australian context

There is no organised prostate cancer screening program in Australia. PSA testing is individual, and doctors are expected to explain the benefits and harms (overdiagnosis, biopsy complications) before ordering it. Asking a patient's permission and documenting the discussion is examinable.